Intelligent Bio Solutions Inc
GBS
Get informed when a big investor buys or sells
+ FollowMarket Cap$433.58K
Close$
Share Statistics
| Market cap | $433,577.00 |
|---|---|
| Enterprise Value | $-1,739,575.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-8.44 |
| Beta | 0 |
| Outstanding Shares | 1,594,496 |
Return
| Return on Equity | -210.74% |
|---|---|
| Return on Assets | -97.25% |
| Return on Invested Capital | -175.26% |
Valuation & Multiples
| P/E Ratio | -0.25 |
|---|---|
| PEG | -1.99 |
| Price to Sales | 0.24 |
| Price to Book Ratio | 0.16 |
| Enterprise Value to Revenue | -0.44 |
| Enterprise Value to EBIT | 0.14 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -1.05 |
| Debt to Equity | 0.33 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About GBS Inc
8 employeesGBS Inc. is on a mission to put the power of non-invasive, real-time diagnostic testing in the hands of patients and their primary health practitioners at point of care. With the world-first Biosensor Platform, GBS Inc. is developing and...